An official website of the United States government
) or https:// means you've safely connected to the .mil website. Share sensitive information only on official, secure websites.
Breast Cancer
Research Highlights/News
2025 | 2024 | 2023 | 2022 | 2021 | 2020
» Look for consumer stories click here
2025
Research Highlights:
2024
Research Highlights:
- CDMRP-FUNDED RESEARCH AIMS TO EFFICIENTLY DETECT BREAST CANCER
- Identification of Actionable Networks Promoting Breast Cancer Progression and Brain Metastasis
- Programmable Probiotics for Targeted Breast Cancer Therapy
Video Highlights:
2023
Press Releases:
- CDMRP-Funded Research Contributed to Test Included in the Defense Health Agency s Pilot Program
July 20, 2023
Research Highlights:
- Inhibition of Myeloid-Derived Suppressor Cell Biogenesis to Improve the Efficacy of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
- Epigenetic Factor CECR2 as a Potential Target in Breast Cancer Metastasis
- The CDMRP Remembers Dr. Susan Love
- Dual-Loading Antibody-Drug Conjugates for Combating Breast Cancer Tumor Heterogeneity and Drug Resistance
- Functional Mechanism and Targeting of Metadherin in Breast Cancer
- Targeting GM-CSF to Inhibit Development of Leptomeningeal Disease from Breast Cancer
- A Novel Tubulin Inhibitor to Overcome Taxane Resistance in Metastatic Breast Cancer
2022
Press Releases:
- Dr. Carolyn Bertozzi Awarded 2022 Nobel Prize in Chemistry
October 7, 2022
Research Highlights:
- Tumor-Specific Fluorescence-Guided Surgery for Breast Cancer
- Overcoming HER2-Based Therapy Resistance in Breast Cancer Brain Metastases through CDK4/6 Inhibition
- Predicting Paclitaxel Sensitivity in Breast Cancer Patients
- Targeting Drug Resistance in Triple-Negative Breast Cancer
- Investigating Estrogen Receptor Mutations in Breast Cancer to Guide New Therapeutic Strategies
- Targeting Prolyl Peptidases in Triple-Negative Breast Cancer
2021
Research Highlights:
- Identifying a Gene Panel to Predict Risk of Recurrence in Patients with Basal-Like Breast Cancer
- Targeting Senescence May Prevent Chemotherapy-Induced Bone Loss in Breast Cancer Patients
- Stromal Lysyl Hydroxylase 2, a Novel Biomarker for Breast Cancer Patient Prognosis
- Cluster of Differentiation 73 (CD73) Blockade Promotes Dendritic Cell Infiltration of Primary Tumors and Activation of Antitumor Immune Responses
- Mitochondria-Targeted Copper-Depleting Nanoparticle Inhibits Triple-Negative Breast Cancer Progression in Mice
- Metabolomic Targeting of Heterogeneous Breast Cancer for Personalized Therapy Development
- Ruxolitinib for the Prevention of Breast Cancer
2020
Research Highlights:
- Fasting-Mimicking Diet Induces Breast Cancer Regression Through Enhanced Effectiveness of Hormone Therapy
- Characterization of Clustered Circulating Tumor Cells to Eliminate Breast Cancer Metastasis
- New Diagnostic and Therapeutic Approaches to Eradicating Recurrent Breast Cancer
- De-Escalating Treatment in HER2+ Breast Cancer: Establishing Effective and Less Toxic Therapy Based on Predictive Biomarkers
- Podcast Discusses the DoD Breast Cancer Research Program and Metastatic Breast Cancer Research
- Lab-on-Chip (LOC) Platform for Assessment of Extracellular Matrix (ECM) Stiffness
- Targeting miR551b to Prevent Tumor Formation and Metastasis of Triple-Negative Breast Cancer (TNBC)
- Death Effector Domain-Containing Protein (DEDD) Vulnerability to Cell Cycle Inhibition in Triple-Negative Breast Cancer (TNBC)
- Enhancing the Cytotoxicity of T-DM1 to Treat HER2+ Breast Cancer
Last updated Monday, November 24, 2025